Overexpression of avb6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. […]Read More… from Overexpression of avb6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
The hemopoietic growth factor, interleukin-3, promotes glucose transport by increasing the specific activity and maintaining the affinity for glucose of plasma membrane glucose transporters in a bone marrow-derived cell line: Possible involvement of phosphorylation in the activation of transporters. […]Read More… from The hemopoietic growth factor, interleukin-3, promotes glucose transport by increasing the specific activity and maintaining the affinity for glucose of plasma membrane glucose transporters in a bone marrow-derived cell line: Possible involvement of phosphorylation in the activation of transporters.
Regulation of glucose transport by interleukin-3 in growth factor-dependent and oncogene-transformed bone marrow derived cell lines. […]Read More… from Regulation of glucose transport by interleukin-3 in growth factor-dependent and oncogene-transformed bone marrow derived cell lines.
Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 activity for glucose is enhanced during the respiratory burst. […]Read More… from Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 activity for glucose is enhanced during the respiratory burst.
Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP and granulocyte-macrophage colony-stimulating factor. […]Read More… from Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP and granulocyte-macrophage colony-stimulating factor.
Telomerase activity in a specific cell subset coexpressing integrin b1/EGFR but not p75NGFR/bcl2 in normal human epithelial cell. […]Read More… from Telomerase activity in a specific cell subset coexpressing integrin b1/EGFR but not p75NGFR/bcl2 in normal human epithelial cell.
Transforming oncogenes regulate glucose transport by increasing transporter affinity for glucose: Contrasting effects of oncogenes and heat stress in a murine bone marrow-derived cell line. […]Read More… from Transforming oncogenes regulate glucose transport by increasing transporter affinity for glucose: Contrasting effects of oncogenes and heat stress in a murine bone marrow-derived cell line.
IL-3 induces apoptosis: Differential effect of IL-3 on the survival and growth response of parental and oncogene-transfected cells […]Read More… from IL-3 induces apoptosis: Differential effect of IL-3 on the survival and growth response of parental and oncogene-transfected cells
N -glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells […]Read More… from N -glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells
Distinct regulation of glucose transport by Interleukin-3 and oncogenes in a murine bone marrow derived cell line […]Read More… from Distinct regulation of glucose transport by Interleukin-3 and oncogenes in a murine bone marrow derived cell line
Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils […]Read More… from Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils
The avb6 integrin regulates its own expression with cell crowding: implications for tumor progression. […]Read More… from The avb6 integrin regulates its own expression with cell crowding: implications for tumor progression.
Interaction of reactive nitrogen and oxygen intermediates in HL60 and dimethyl sulphoxide-differentiated HL60 cells […]Read More… from Interaction of reactive nitrogen and oxygen intermediates in HL60 and dimethyl sulphoxide-differentiated HL60 cells
Direct integrin avb6-Erk binding: implications for tumour growth […]Read More… from Direct integrin avb6-Erk binding: implications for tumour growth
Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the b6 integrin subunit. […]Read More… from Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the b6 integrin subunit.
avb6 Integrin- A marker for the malignant potential of epithelial ovarian cancer […]Read More… from avb6 Integrin- A marker for the malignant potential of epithelial ovarian cancer
Proteomic profiling of proteins associated with urokinase plasminogen activator receptor (uPAR) in colon cancer cells using an antisense approach […]Read More… from Proteomic profiling of proteins associated with urokinase plasminogen activator receptor (uPAR) in colon cancer cells using an antisense approach
Down regulation of urokinase plasminogen activator expression inhibits Erk signaling with concomitant suppression of matrix metalloprotease-9 (MMP-9) due to loss of uPAR-b1 integrin complex in colon cancer. […]Read More… from Down regulation of urokinase plasminogen activator expression inhibits Erk signaling with concomitant suppression of matrix metalloprotease-9 (MMP-9) due to loss of uPAR-b1 integrin complex in colon cancer.
Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. […]Read More… from Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
Expression and localization of avb6 integrin in extraplacental fetal membranes: possible role in human parturition. […]Read More… from Expression and localization of avb6 integrin in extraplacental fetal membranes: possible role in human parturition.
Cell-free 59 kDa Immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma. […]Read More… from Cell-free 59 kDa Immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma.
Proteomics based identification of hatoglobin-1 precursor as a novel circulating biomarker for ovarian cancer. […]Read More… from Proteomics based identification of hatoglobin-1 precursor as a novel circulating biomarker for ovarian cancer.
Enhanced expression of peroxisome proliferator receptor g expression in ovarian carcinoma. […]Read More… from Enhanced expression of peroxisome proliferator receptor g expression in ovarian carcinoma.
Strategies for revealing lower abundance proteins in two-dimensional protein maps. […]Read More… from Strategies for revealing lower abundance proteins in two-dimensional protein maps.
Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer […]Read More… from Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer
Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion […]Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion
Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion […]Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion
Momelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancer […]Read More… from Momelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancer
Collaboration of Epithelial Mesenchymal Transition and Cancer Stem Cells: Sinister Routes for Chemoresistant Recurrent Ovarian Cancer […]Read More… from Collaboration of Epithelial Mesenchymal Transition and Cancer Stem Cells: Sinister Routes for Chemoresistant Recurrent Ovarian Cancer
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets […]Read More… from Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
New insights into mammalian sugar transport and its regulation at the plasma membrane […]Read More… from New insights into mammalian sugar transport and its regulation at the plasma membrane
Epithelial-to-mesenchymal transition as a robust biomarker and a novel strategy to enhance response to immune checkpoint blockade and targeted therapy in patients with metastatic renal cell carcinoma […]Read More… from Epithelial-to-mesenchymal transition as a robust biomarker and a novel strategy to enhance response to immune checkpoint blockade and targeted therapy in patients with metastatic renal cell carcinoma
Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets […]Read More… from Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence […]Read More… from The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
Immunohistochemistry and in situ hybridization of human carcinomas […]Read More… from Immunohistochemistry and in situ hybridization of human carcinomas
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer […]Read More… from Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer
Translational Proteomics: Developing a predictive capacity. […]Read More… from Translational Proteomics: Developing a predictive capacity.
An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum […]Read More… from An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma […]Read More… from Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma
A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus […]Read More… from A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus
Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment […]Read More… from Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment
Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer […]Read More… from Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer
The impact of low dose carcinogens and environmental disrupters on tissue invasion and metastasis. […]Read More… from The impact of low dose carcinogens and environmental disrupters on tissue invasion and metastasis.
Oral Cholera vaccines containing b-subunit-killed whole cells and whole cells only. Cross reacting antigens of the members of family Vibrionaceae and the vaccines. […]Read More… from Oral Cholera vaccines containing b-subunit-killed whole cells and whole cells only. Cross reacting antigens of the members of family Vibrionaceae and the vaccines.
The Human promyelocytic HL60 cell line: A model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate. […]Read More… from The Human promyelocytic HL60 cell line: A model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate.
Glycolytic, glutaminolytic and pentose-phosphate pathways in promyelocytic HL60 and DMSO-differentiated HL60 cells. […]Read More… from Glycolytic, glutaminolytic and pentose-phosphate pathways in promyelocytic HL60 and DMSO-differentiated HL60 cells.
Purine metabolism in promyelocytic HL60 and dimethyl sulphoxide-differentiated HL60 cells. […]Read More… from Purine metabolism in promyelocytic HL60 and dimethyl sulphoxide-differentiated HL60 cells.
Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells. […]Read More… from Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer. […]Read More… from Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
Targeted disruption of JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden. […]Read More… from Targeted disruption of JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden.
Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFkB-mediated induction of MMP2. […]Read More… from Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFkB-mediated induction of MMP2.
Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients. […]Read More… from Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients.
Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics. […]Read More… from Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics.
A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer. […]Read More… from A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. […]Read More… from Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells […]Read More… from Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
Molecular pathways regulating epidermal growth factor-induced epithelio-mesenchymal transition in human ovarian surface epithelium. […]Read More… from Molecular pathways regulating epidermal growth factor-induced epithelio-mesenchymal transition in human ovarian surface epithelium.
Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer. […]Read More… from Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.
Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody Microarrays- Chapter 20. […]Read More… from Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody Microarrays- Chapter 20.
The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression. […]Read More… from The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden […]Read More… from Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer […]Read More… from Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer
Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells. […]Read More… from Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells.
Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer. […]Read More… from Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer.
The Potential Role of Interleukin-11 in Epithelial Ovarian Cancer […]Read More… from The Potential Role of Interleukin-11 in Epithelial Ovarian Cancer
Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods […]Read More… from Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
In Vitro and In Vivo Toxicity and Biodistribution of Paclitaxel-Loaded Cubosomes as a Drug Delivery Nanocarrier: A Case Study Using an A431 Skin Cancer Xenograft Model […]Read More… from In Vitro and In Vivo Toxicity and Biodistribution of Paclitaxel-Loaded Cubosomes as a Drug Delivery Nanocarrier: A Case Study Using an A431 Skin Cancer Xenograft Model
TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells […]Read More… from TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment […]Read More… from Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism […]Read More… from Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism
In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma. […]Read More… from In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma.
Determinants of Resistance to VEGF-TKI and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma […]Read More… from Determinants of Resistance to VEGF-TKI and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma
Effect of silencing neutrophil gelatinase-associated lipocalin in ovarian cancer cells on epithelio-mesenchymal transition. […]Read More… from Effect of silencing neutrophil gelatinase-associated lipocalin in ovarian cancer cells on epithelio-mesenchymal transition.
Ascites induces modulation of a6 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma. […]Read More… from Ascites induces modulation of a6 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix micro-environment. […]Read More… from Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix micro-environment.
Proteomics tracking of serum protein isoforms as screening biomarkers of ovarian cancer. […]Read More… from Proteomics tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
a2b1 integrin affects metastatic ability of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. […]Read More… from a2b1 integrin affects metastatic ability of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. […]Read More… from Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition.
Immunohistochemical perspective of PPARb and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours […]Read More… from Immunohistochemical perspective of PPARb and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
Epithelial-Mesenchymal interconversions in normal ovarian epithelium and ovarian carcinomas: an exception to the norm […]Read More… from Epithelial-Mesenchymal interconversions in normal ovarian epithelium and ovarian carcinomas: an exception to the norm
Cross talk of signals between EGFR and IL-6R via JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. […]Read More… from Cross talk of signals between EGFR and IL-6R via JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
Epidermal growth factor induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of a6b1 integrin. […]Read More… from Epidermal growth factor induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of a6b1 integrin.
Neuronal transcription factor Brn-3a is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer. […]Read More… from Neuronal transcription factor Brn-3a is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer.
Multicellular spheroids in ovarian cancer metastases: Biology and pathology. […]Read More… from Multicellular spheroids in ovarian cancer metastases: Biology and pathology.
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling […]Read More… from Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
2D-PAGE of Ovarian Cancer: Analysis of soluble and insoluble fractions using narrow pH ranges […]Read More… from 2D-PAGE of Ovarian Cancer: Analysis of soluble and insoluble fractions using narrow pH ranges
Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profiles […]Read More… from Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profiles
Contribution of fibroblast and mast cell (afferent) and tumor (efferent) IL-6 effects within the tumor micro-environment […]Read More… from Contribution of fibroblast and mast cell (afferent) and tumor (efferent) IL-6 effects within the tumor micro-environment
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemo resistant ovarian tumors […]Read More… from Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemo resistant ovarian tumors
Attributes of Oct4 in stem cell biology: Perspectives on cancer stem cells of the ovary […]Read More… from Attributes of Oct4 in stem cell biology: Perspectives on cancer stem cells of the ovary
Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer […]Read More… from Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance […]Read More… from Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance
Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research […]Read More… from Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. […]Read More… from Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.
Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets. […]Read More… from Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets.
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer […]Read More… from Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
Professor Nuzhat AhmedProfessor Nuzhat Ahmed
Professor Nuzhat Ahmed